Sentences with phrase «for lung adenocarcinoma»
«Our combined findings demonstrate that p53 status represents a critical determinant in selection of therapeutic strategies for lung adenocarcinoma patients.»
http://www.cancernetwork.com/
Even some known cancer genes for lung adenocarcinoma, one of the most intensively studied cancers, haven't popped out in cancer genome surveys.
Not exact matches
A large - scale genetic study of the links between telomere length and risk for five common cancers finds that long telomeres are associated with an increased risk of lung adenocarcinoma.
They found that longer telomeres were significantly associated with increased risk for lung cancer — specifically lung adenocarcinoma, which more than doubled in risk for every 1000 base pair increase in telomere length.
Adenocarcinomas account for some 40 percent of all lung cancers diagnosed.
In this study, the researchers focused on a type of non-small cell lung cancer called lung adenocarcinoma, which accounts for about 40 percent of lung cancers.
One major change is the recommendation to test for alterations to the gene ROS1 in all cases of lung adenocarcinoma, which make up about half of all cases of non-small cell lung cancer.
Verma has successfully developed lentiviral vector - mediated mouse models for glioblastoma, lung adenocarcinoma and small cell lung cancer (SCLC).
Xia Y, Liu Y - L, Xie Y, Zhu W, Guerra F, Shen S, Yeddula N, Fischer W, Low W, Zhou X, Zhang Y, Oldfield E, Verma IM (2014) A combination therapy for KRAS - driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin.
Validation of a cell cycle progression score for five - year mortality risk in patients with stage I lung adenocarcinoma.
We will identify where the guideline strengthens or reaffirms the 2013 recommendations for patients with lung adenocarcinoma, as well recommendations for testing for several new genes.
21) Somwar R, Erdjument - Broonage H, Larsson E, Shum D, Lockwood WW, Yang G, Sander C, Ouerfelli O, Tempst PJ, Djaballah H, Varmus H (2011) SOD1 is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines.
DIM's history for cancer prevention and therapy began when a mouse study showed its promising results in tobacco smoke, carcinogen - induced, lung adenocarcinoma.